Opioid labelling debated at FDA Hearing
Advocates and pain management groups aired concerns recently over a citizen petition to change opioid labeling during the first of a 2-day FDA hearing.
Advocates and pain management groups aired concerns recently over a citizen petition to change opioid labeling during the first of a 2-day FDA hearing.
Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – Deaths and liver transplants related to paracetamol overdoses have decreased significantly due to UK legislation which… read more.
In a recent Clinical Crossroads article Dr. Dan Alford from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) suggests that prescription opioid abuse can be… read more.
EMA Highlights by Gary Finnegan – Pharmaceutical companies will have to pay more to have their new medicines evaluated, if the European Medicines Agency is to balance its… read more.
EMA Highlights by Gary Finnegan – Several new medicines have been approved by the EMA’s influential Committee for Medicinal Products for Human Use (CHMP), including the first non-surgical… read more.
EMA Highlights by Eoghan McNeill – The EMA has published revised guidelines on the evaluation of anti-cancer medicines to take account of advances in research and new therapeutic… read more.
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new… read more.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.
by Gary Finnegan – EMA Highlights – The EMA has given its backing to a number of medicines including:
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.